HEALTHY EXTRACTS INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data HEALTHY EXTRACTS INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	0.16	0.13	0.07	0.75	1.3	1.68	2.25	2.49	3.11	4.51
Cost of revenue	0.03	0	0.03	0.52	1.86	0.98	0.88	0.86	1.2	2.09
Gross profit	0.14	0	0.04	0.22	-0.58	0.7	1.37	1.62	1.91	2.42
General and administrative	0.76	0.54	0.31	1.16	1.47	2.58	2.28	3.87	2.09	3.37
Operating expenses	0.96	0.95	0.55	1.16	3.05	2.58	2.28	3.87	2.09	3.37
Operating income	-0.83	-3.64	-3.32
Other non-operating income						-0.1	-0.07	-0.23	-0.66	0.06
Income tax							0	0	0	0
Net income	-3.37	-3.56	-3.33	0.63	-2.58	-1.99	-0.98	-2.47	-0.84	-0.88
EBITDA	-0.82	-3.64	-3.31
EPS, basic	-55.37	-15.82	-1.21	0.01	-0.01
EPS, diluted	-55.37	-15.82	-1.21	0.01	-0.01
Shares, basic (weighted)	0.06	0.23	2.75	111	237
Shares, diluted (weighted)	0.06	0.23	2.75	111	237

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	0.02	0.08	0	0.13	0.06	0.22	0.07	0.02	0.11	0.15
Receivables	0.07	0.02		0.03	0.01	0.13	0.11	0.03	0.01	0.19
Inventory		0.05	0	3.08	2.42	1.96	1.82	1.63	1.36	0.84
Other current assets	0.01									0
Total current assets	0.14	0.15	0.01	3.24	2.49	2.31	2.04	1.9	1.66	1.33
Lease right-of-use assets							0	0.07	0.01	0
Goodwill		0.84		0.19	0.19	0.19	0.19	0.19	0.19	21.1
Intangible assets	0	0	0	0.02	0.01	0	0.01	0	0	4.23
Long-term investments									0
Total assets	0.15	1.12	0.09	3.45	3.12	3.03	2.78	2.64	2.38	27.8
Accounts payable	0	0.07	0.06	0.02	0.06	0.04	0.09	0.12	0.05	0.11
Accrued liabilities				0.05	0.01	0.06	0.09	0.22	0.25	0.61
Total current liabilities	2.51	2.3	3.65	4.32	0.26	0.56	0.9	1.68	1.34	1.76
Lease liabilities							0	0.01	0	0.34
Total liabilities	2.51	2.3	3.65	4.32	0.26	0.56	0.91	1.68	1.97	3.8
Paid-in capital	1.74	6.5	7.44	9.39	15.5	17.1	17.5	19	19.3	43.8
Retained earnings	-4.12	-7.68	-11	-10.4	-13	-14.9	-15.9	-18.4	-19.2	-20.1
Treasury stock								0	-0.01	-0.01
Shareholders' equity	-2.36	-1.18	-3.56	-0.87	2.85	2.47	1.87	0.95	0.15	24
Total equity	-2.36	-1.18	-3.56	-0.87	2.85	2.47	1.87	0.95	0.15	24
Total liabilities and equity	0.15	1.12	0.09	3.45	3.12	3.03	2.78	2.64	2.38	27.8
Shares outstanding	0.07	0.9	3.03	122	309	338	2.88	2.95	2.99	16.9

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-3.37	-3.64	-3.32	0.63	-2.58	-1.99	-0.98	-2.47	-0.84	-0.88
Depreciation and amortization	0	0	0.01	0.01	0.01	0.01
Stock-based compensation				0.11		0	0
Change in receivables	0.01	-0.05	-0.02	0.03	-0.01	-0.12	0.03	0.08	0.02	-0.14
Change in inventory		-0	-0.05	1.33	-0.66	0.46	0.14	0.19	0.27	0.55
Change in payables	-0.01	0.04	-0.01	-0.04	0.04	-0.03	0.05	0.03	-0.06	0.02
Cash from operations	-0.54	-0.67	-0.33	-1.73	-1.9	-0.9	-0.39	-0.42	0.28	0.17
Capital expenditures				-0.02		0	-0.01	0
Cash from investing	-0.05	-0.04	0.05	0.06	-0.12	-0.1	-0.01	0	0	0.06
Stock issued					4.41	1	-0.01	-0.09	0
Cash from financing	0.61	0.77	0.2	1.81	1.94	1.16	0.24	0.37	-0.19	-0.19
Net change in cash	0.02	0.06	-0.08	0.13	-0.07	0.16	-0.16	-0.05	0.09	0.03
Free cash flow				-1.75		-0.9	-0.4	-0.42

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.10 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	61.1%	Gross profit / revenue.
Net margin	-14.0%	Net income / revenue.
Operating cash flow margin	8.0%	Cash from operations / revenue.
Return on equity (ROE)	-3.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-2.7%	Net income / average total assets.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	44.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	26.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	28.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	26.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	20.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-41.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	15,746.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	134.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	53.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	1,070.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	115.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	54.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.20x	Current assets / current liabilities.
Quick ratio	0.10x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.02x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	31.2%	Total liabilities / total assets.
Working capital	-$6.7M	Current assets - current liabilities.
Goodwill and intangibles / assets	91.8%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$7.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.19x	Revenue / average total assets.
Inventory turnover	3.79x	Cost of revenue / average inventory.
Days inventory	96 days	365 x average inventory / cost of revenue.
Receivables turnover	10.4x	Revenue / average receivables.
Days sales outstanding	35 days	365 x average receivables / revenue.
Days payables	51 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	81 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
Book value per share	$1.52	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$0.51	Tangible book value / shares outstanding.
Cash per share	$0.01	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$16.2M	Share price x shares outstanding.
Enterprise value	$16.0M	Market cap + total debt - cash - short-term investments.
P/S	2.58x	Market cap / revenue.
P/B	0.72x	Market cap / shareholders' equity. Only when equity is positive.
P/OCF	32.4x	Market cap / cash from operations, when positive.
EV/Sales	2.55x	Enterprise value / revenue.
Earnings yield	-5.4%	Net income / market cap (the inverse of P/E).

What was HEALTHY EXTRACTS INC.'s revenue in fiscal 2025?

HEALTHY EXTRACTS INC. reported revenue of $4.5M for fiscal 2025, 44.9% higher than the year before.

Was HEALTHY EXTRACTS INC. profitable in fiscal 2025?

No. It reported a net loss of $881.1K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to HEALTHY EXTRACTS INC.